The meeting will be held at The Biopark, Hertfordshire.
Meeting Chair: Dr Eleanor Berrie, Clinical BioManufacturing Facility, University of Oxford, UK
As both genomic and post-genomic analyses of pathogens and disease has advanced the production of successful recombinant vaccines we now require the strategies to both * select appropriate molecules and *deliver these vaccines effectively to stimulate protective immune responses.
Both candidate discovery and the tools for delivering vaccines effectively will be explored and discussed at this one day event
This meeting has CPD accreditation
The agenda includes:
Development of recombinant vaccines against nematode species of ruminants
Professor Jacqui Matthews, Royal (Dick) School of Veterinary Studies, University of Edinburgh
Development of a thermostable and transcutaneous adenovirus vector vaccine designed to induce broad CD8 T-cell responses to HIV
Professor J George Dickson, Director Institute of Biomedical & Life Sciences, South West London Academic Network, UK
Talk to be confirmed
Dr David Paton, Institute for Animal Health, UK
Methods for delivery of GM vaccines to stimulate appropriate, protective responses
Dr David JM Lewis, St George's Hospital, UK
Can Mucosal Vaccines make Needles a Thing of the Past?
Dr. Valerie Ferro, University of Strathclyde, Scotland
Recombinant avipoxvirus vaccines
Dr Michael A. Skinner, Imperial College London,
Clinical trials of a novel influenza vaccine
Sarah C. Gilbert, Reader in Vaccinology, Jenner Institute, Oxford
Optimizing vaginal responses to HIV vaccines
Professor Robin Shattock, St Georges University of London, UK
To book a place at this meeting or keep up to date with the agenda, please visit:www.regonline.co.uk/recvaccine2010
|